slotkoers
Korea S.E.
00:00:00 19-01-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.915
KRW
|
-8,91%
|
|
-.--%
|
-22,27%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
544.451
|
267.103
|
296.079
|
197.660
|
76.369
|
98.182
|
Bedrijfswaarde
1 |
480.084
|
194.005
|
255.027
|
168.371
|
65.212
|
84.938
|
K/w-verhouding
|
-67,9
x
|
-26,2
x
|
-9,65
x
|
-3,62
x
|
-2,5
x
|
-6,82
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
275.671
x
|
-
|
4.950
x
|
2.920
x
|
370
x
|
1.310
x
|
Bedrijfswaarde/omzet
|
243.081
x
|
-
|
4.263
x
|
2.487
x
|
316
x
|
1.133
x
|
Bedrijfswaarde/EBITDA
|
-72,5
x
|
-23,1
x
|
-10,8
x
|
-4,55
x
|
-2,94
x
|
-7,67
x
|
Bedrijfswaarde/FCF
|
-92,2
x
|
-13
x
|
26,8
x
|
-3,37
x
|
-3,64
x
|
-11,6
x
|
FCF Yield
|
-1,08%
|
-7,7%
|
3,74%
|
-29,7%
|
-27,5%
|
-8,63%
|
Price to Book
|
8,4
x
|
3,94
x
|
6,48
x
|
3,88
x
|
3,08
x
|
6,83
x
|
Aantal aandelen (in duizenden)
|
17.014
|
17.277
|
17.793
|
25.670
|
25.670
|
26.182
|
Referentieprijs
2 |
32.000
|
15.460
|
16.640
|
7.700
|
2.975
|
3.750
|
Datum van publicatie
|
20-03-19
|
19-03-20
|
17-03-21
|
16-03-22
|
15-03-23
|
18-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1,975
|
-
|
59,82
|
67,7
|
206,6
|
74,96
|
EBITDA
1 |
-6.621
|
-8.401
|
-23.715
|
-37.006
|
-22.208
|
-11.070
|
Bedrijfsresultaat (EBIT)
1 |
-6.914
|
-10.104
|
-25.507
|
-38.223
|
-23.290
|
-12.102
|
Operationele Marge
|
-350.051,85%
|
-
|
-42.641,13%
|
-56.460,31%
|
-11.273,14%
|
-16.143,55%
|
Resultaat voor belastingen (EBT)
1 |
-6.976
|
-10.158
|
-30.678
|
-44.033
|
-30.548
|
-14.247
|
Nettowinst (verlies)
1 |
-6.976
|
-10.158
|
-30.678
|
-44.033
|
-30.548
|
-14.247
|
Nettomarge
|
-353.205,56%
|
-
|
-51.285,28%
|
-65.043,78%
|
-14.786,41%
|
-19.004,64%
|
WPA
2 |
-471,5
|
-589,6
|
-1.724
|
-2.126
|
-1.190
|
-550,2
|
Free Cash Flow
1 |
-5.208
|
-14.934
|
9.531
|
-49.943
|
-17.903
|
-7.333
|
FCF-marge
|
-263.715,28%
|
-
|
15.933,81%
|
-73.773,12%
|
-8.665,74%
|
-9.782,31%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
20-03-19
|
19-03-20
|
17-03-21
|
16-03-22
|
15-03-23
|
18-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
64.367
|
73.098
|
41.052
|
29.289
|
11.157
|
13.244
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-5.208
|
-14.934
|
9.531
|
-49.943
|
-17.903
|
-7.333
|
ROE (netto-inkomsten/eigen vermogen)
|
-20%
|
-15,3%
|
-54,1%
|
-91,1%
|
-80,7%
|
-68,9%
|
ROA (netto-inkomsten/totale activa)
|
-11,2%
|
-5,46%
|
-10,8%
|
-23,6%
|
-26,7%
|
-22,6%
|
Totale activa
1 |
62.408
|
185.896
|
283.747
|
186.246
|
114.258
|
63.149
|
Nettoactief per aandeel
2 |
3.808
|
3.923
|
2.569
|
1.983
|
966,0
|
549,0
|
Cashflow per aandeel
2 |
1.774
|
2.675
|
2.121
|
1.474
|
506,0
|
382,0
|
Capex
1 |
810
|
1.273
|
4.213
|
1.176
|
1.997
|
69,3
|
Capex/omzet
|
41.010,87%
|
-
|
7.043,84%
|
1.737,58%
|
966,83%
|
92,47%
|
Datum van publicatie
|
20-03-19
|
19-03-20
|
17-03-21
|
16-03-22
|
15-03-23
|
18-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -22,27% | 64,97 mln. | | +8,96% | 105 mld. | | -1,43% | 104 mld. | | +4,40% | 22,94 mld. | | -12,15% | 22,34 mld. | | -4,36% | 19,25 mld. | | -39,98% | 17,08 mld. | | -10,04% | 16,96 mld. | | +38,61% | 12,63 mld. | | +313,59% | 8,49 mld. |
Biotherapeutische geneesmiddelen
|